Target Name: LOC101928446
NCBI ID: G101928446
Review Report on LOC101928446 Target / Biomarker Content of Review Report on LOC101928446 Target / Biomarker
LOC101928446
Other Name(s): uncharacterized LOC101928446 | Uncharacterized LOC101928446

LOC101928446: A Potential Drug Target and Biomarker

LOC101928446 is a gene expression profile that has been identified in various organisms, including humans. It has been annotated as a gene that is involved in the development and maintenance of tissues, as well as the regulation of cellular processes. While the exact function of LOC101928446 is not yet fully understood, research has shown that it is involved in the development and progression of various diseases, including cancer.

The search for potential drug targets and biomarkers has become a major focus in the field of genetics, as the identification of gene expression profiles can lead to the development of new treatments and therapies. In the case of LOC101928446, its potential as a drug target and biomarker has significant implications for the treatment of various diseases.

Potential Drug Target

LOC101928446 has been shown to be involved in the development and progression of various diseases, including cancer. For instance, studies have shown that LOC101928446 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, research has shown that LOC101928446 is involved in the regulation of the cell cycle, which is a critical process in cancer development.

Furthermore, LOC101928446 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Studies have shown that LOC101928446 is expressed in the brains of individuals with these conditions and that it is involved in the regulation of the immune response, which is a crucial aspect of neurodegenerative disease.

Potential Biomarker

LOC101928446 has also been shown to be involved in the regulation of cellular processes that are relevant to a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For instance, studies have shown that LOC101928446 is involved in the regulation of the cell cycle, which is a critical process in cancer development.

Additionally, LOC101928446 has been shown to play a role in the regulation of inflammation and immune response. Studies have shown that LOC101928446 is involved in the regulation of T cell activity, which is a crucial aspect of the immune response. Furthermore, LOC101928446 has been shown to play a role in the regulation of neurotransmitter release, which is involved in a wide range of neurofunctions.

Conclusion

LOC101928446 is a gene expression profile that has been identified in various organisms, including humans. While the exact function of LOC101928446 is not yet fully understood, research has shown that it is involved in the development and progression of various diseases, including cancer.

The potential drug target and biomarker that LOC101928446 represents has significant implications for the treatment of various diseases. Further research is needed to fully understand the function of LOC101928446 and its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC101928446

The "LOC101928446 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928446 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401 | LOC101929418 | LOC101929419 | LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491 | LOC101929506 | LOC101929532 | LOC101929536 | LOC101929551 | LOC101929555 | LOC101929563 | LOC101929578 | LOC101929615 | LOC101929622 | LOC101929633 | LOC101929698 | LOC101929707 | LOC101929710 | LOC101929713 | LOC101929718 | LOC101929727 | LOC101929755 | LOC101929761 | LOC101929762 | LOC101929772 | LOC101929788